SVP, Head of Global Chemical Engineering and Technology Center, Porton Pharma Solutions
31-year experience in Pharma industry
Joined Porton JSTAR in 2014. previously served as the Head of Center for Pharma Crystallization, Dr. Jian Wanghas over 30 years of process R&D experience specialized in API crystallization, reaction engineering, and PAT applications. Jian earned her Ph.D. in Chemical Engineering in 1994 from University of Pittsburgh, supervised by Prof. Donna Blackmond and Prof. Irving Winder. She has authored over 20 peer-reviewed articles and holds 6 patents, 5 on API crystallization.
From 1994 to 2005. Jian worked at Merck, addressing bottleneck process R&D issues via reaction engineering, API crystallization, and PAT application, as well as pilot plant process execution. She consulted at Mettler Toledo AutoChem from 2005-2010 and served as VP of Crystallization Development at Crystal Pharmatech from 2011-2013. Since 2014. she established a state-of-the-art crystallization center at J-STAR Research, working on API isolation challenges across developmental stages and integrating drug formulation services with API crystallization R&D.
Listening to clients’ needs, building up the team’s technical capabilities, and providing the right technical solutions have been Jian’s focus for decades. Her dedication and contributions to pharma process R&D have served broad needs of diverse global clients with technical rigor, synergy and efficiency.
博騰股份為全球藥企、生物科技公司、科研機(jī)構(gòu)等提供從臨床前研究到藥品上市全生命周期所需的小分子藥物、多肽與寡核苷酸藥物、蛋白與偶聯(lián)藥物以及細(xì)胞與基因治療藥物等一站式服務(wù)解決方案，研發(fā)、生產(chǎn)、運(yùn)營(yíng)場(chǎng)地覆蓋中國(guó)(重慶、上海、四川、江蘇、江西、湖北)、美國(guó)、斯洛文尼亞、比利時(shí)、瑞士和丹麥等地。我們致力于以客戶為中心，為客戶提供卓越的全球化、端到端CDMO服務(wù)，讓好藥更早惠及大眾。
